Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT03469128 |
Other study ID # |
2016-2017PTBUE |
Secondary ID |
IRB Protocol CL- |
Status |
Completed |
Phase |
Phase 1
|
First received |
|
Last updated |
|
Start date |
January 1, 2016 |
Est. completion date |
January 1, 2020 |
Study information
Verified date |
March 2021 |
Source |
British University In Egypt |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The present research was aimed at comparing the effects of Cognitive Processing Therapy (CPT)
with the effects of Sertraline in treating patients who have dual diagnosis PTSD & SUD. The
present study examines the extent to which CPT is effective in treating PTSD symptoms for
patients with PTSD and SUD.
Description:
Patients with co-occurrence PTSD & SUD disorders were grouped into 3 groups: first: Cognitive
Processing Therapy (CPT) in which participants completed 12 sessions of CPT. Second: were
treated by Sertraline. Third: a placebo control group.